One meeting does not a partnership make, but Google’s interest in working with FDA on adverse event tracking should pique interest among those hoping to improve the existing systems.
Peter Lurie, FDA associate commissioner for policy and planning, along with Office of Surveillance and Epidemiology leadership and top-level staff...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?